- Country: Russia
- Summary: The Supply of Drugs for Medical Use (mnn: Metamizole Sodium; Bacitrapin+neomycin; Dexpanthenol; Vaseline; Tolperisone+[lidocaine]; Cholina Salicylate).
- RUT Ref No: 68082785
- Deadline: 29 Jun 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 23274.60
- Notice Type: Tender
- Document Ref. No.: 0318300394322000016
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The supply of drugs for medical use (MNN: metamizole sodium; bacitrapin+neomycin; dexpanthenol; vaseline; tolperisone+[lidocaine]; cholina salicylate).
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINThe Supply of Drugs for Medical Use (mnn: Metamizole Sodium; Bacitrapin+neomycin; Dexpanthenol; Vaseline; Tolperisone+[lidocaine]; Cholina Salicylate). - Russia Tender
The STATE BUDGETARY INSTITUTION OF HEALTH "CITY POLYCLINIC NO. 26 OF THE CITY OF KRASNODAR" OF THE MINISTRY OF HEALTH OF THE KRASNODAR TERRITORY, a Government sector organization in Russia, has announced a new tender for The Supply of Drugs for Medical Use (mnn: Metamizole Sodium; Bacitrapin+neomycin; Dexpanthenol; Vaseline; Tolperisone+[lidocaine]; Cholina Salicylate).. This tender is published on RussiaTenders under RUT Ref No: 68082785 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-06-29.
The estimated tender value is RUB 23274.60, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
